Mesenchymal Stem Cell Differentiation via NICD Transfection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing methods for redirecting the developmental potential of mesenchymal stem cells to include neuronal and myogenic lineages also restrict their ability to differentiate into their normal mesenchymal lineages, such as osteocytes and adipocytes, with unclear mechanisms and unknown long-term potential, which is crucial for therapeutic applications in neurodegenerative disorders and musculoskeletal issues.
Innovation Solution
Transfecting marrow adherent stromal cells with a nucleic acid encoding the Notch intracellular domain (NICD) to alter their developmental potential, allowing transient or stable expression, thereby reducing their osteogenic and adipogenic differentiation while potentially enhancing neural and myogenic differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If mesenchymal stem cells are treated to shift developmental potential toward neuronal and myogenic lineages, then neurogenic and myogenic differentiation is improved, but osteogenic and adipogenic differentiation is reduced
Solution Approach 1:
The patent applies dynamic control of the Notch signaling pathway through temporal modulation of NICD expression. By controlling the duration and intensity of NICD exposure, the system dynamically shifts cell fate decisions between mesenchymal and non-mesenchymal lineages, allowing adaptive redirection of developmental potential while maintaining controlled differentiation outcomes
Solution Approach 2:
The patent changes key parameters of the Notch signaling pathway by introducing exogenous NICD at controlled concentrations and time points. This parameter modification alters the signaling threshold and duration, enabling precise control over lineage commitment decisions and achieving versatile developmental redirection with controlled differentiation stability
2Reliability
If the Notch signaling system is manipulated to block neural differentiation, then mesenchymal lineage maintenance is improved, but neural differentiation capability is reduced
Solution Approach 1:
The patent inverts the normal Notch signaling function by introducing constitutively active NICD that cannot be regulated by traditional ligand-receptor interactions. This inversion bypasses the normal blocking mechanism and forces neural differentiation programs to activate, reversing the typical Notch-mediated suppression of neurogenesis while maintaining mesenchymal cell identity
3Adaptability or versatility
If transient expression of NICD is used, then flexibility in differentiation control is improved, but stable long-term differentiation is reduced
Solution Approach 1:
The patent applies preliminary action by providing a nucleic acid sequence that encodes NICD, which is then expressed transiently to initiate differentiation programs before being removed. This preliminary NICD exposure primes the cells for stable long-term differentiation into non-mesenchymal lineages, achieving both flexible control during the process and stable outcomes afterward
Data Source
Figure 1A~1B
Figure 2
Figure 3
AI summary
Disclosed herein are methods and compositions useful for altering the differentiation potential of marrow adherent stromal cells, also known as mesenchymal stem cells. In certain embodiments, the normal tendency for these cells to differentiate into osteogenic and adipogenic lineages is restricted.